BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 20, 2011
View Archived Issues
Abiraterone acetate plus prednisone provides clinical benefit in metastatic CRPC
Read More
New RAC-alpha serine/threonine-protein kinase inhibitors claimed
Read More
Novel PI3K-gamma inhibitors synthesized at Taisho
Read More
Stem cell therapy shows promise to treat diabetic retinopathy and optical neuropathy
Read More
Critical Outcome Technologies begins development of oral COTI-2 formulation
Read More
Armodafinil improves severe sleepiness in subjects with shift work disorder
Read More
Chemical genetics screening platform identifies new agent and target for influenza therapy
Read More
New liver X receptor agonists described by Merck & Co.
Read More
New tyrosine-protein kinase JAK3 inhibitors patented by Palau Pharma
Read More
Isis begins phase I trial of ISIS-TTRRx for transthyretin amyloidosis
Read More
Zydus-Cadila presents new peptidomimetic GLP-1 agonists/glucagon receptor antagonists
Read More
BAY-94-8862 enters phase II trial in patients with chronic heart failure and kidney disease
Read More
Medistem completes preclinical animal safety studies requested by FDA
Read More
Allergan patents novel alpha2C-adrenoceptor agonists
Read More
Resolve Therapeutics raises funds in series A financing round, plans next step for RSLV-125
Read More
Northwest Biotherapeutics and Fraunhofer enter partnership for DCVax-L
Read More
Ludwig Institute for Cancer Research and Polaris Pharmaceuticals form collaboration
Read More
FDA places new restrictions on use of rosiglitazone-containing medicines
Read More
TheraVida begins phase II trial of THVD-201
Read More
Japanese authorities approve additional indications for Novastan and Slonnon
Read More
Daiichi Sankyo's Rifadin approved for additional indication in Japan
Read More
Cell Therapeutics to meet with FDA next month regarding resubmission of pixantrone NDA
Read More
Eisai receives Japanese approval for additional indication of Vasolan formulations
Read More
Enzon Pharmaceuticals discontinues PEG-SN38 program in colorectal carcinoma
Read More
Omeros begins phase III program for OMS-103HP and OMS-302
Read More